At the Junction: Why Your Connection Choice Is Determining Your Bone Levels

Most discussions about implant-abutment connections focus on the microgap — the interface between implant and abutment where bacteria accumulate. And bacteria do accumulate there; that's been documented since the 1990s. But reducing this to a bacterial contamination problem misses the more important mechanism.

Hermann and colleagues demonstrated that the critical driver of crestal bone loss isn't simply the presence of a gap or even the bacteria within it. It's micromovement. When the connection flexes under occlusal load, it creates a pumping action — drawing bacteria and inflammatory mediators in and out of the interface with every bite. That dynamic movement stimulates a biologic response at the bone level. The body interprets mechanical instability as a threat and resorbs accordingly.

This reframes the entire conversation. The question isn't is there a gap? — there always is. The question is how much does the connection move under load? The answer determines your bone levels.

Connection stability is what saves the bone.

External hex connections belong to a prior era of implant dentistry. The flat butt-joint design, with its short vertical wall height and high micromovement under lateral load, is associated with significant crestal bone loss — particularly when placed subcrestally, where the movement is amplified and the inflammatory response is initiated deep to the crest (Koutouzis, 2019). Screw loosening is common. The connection is mechanically unstable by design.

Nobody placing implants today should be selecting external hex as their primary connection. It's worth understanding for what it tells us about the biology, but the clinical conversation has moved on — to what's happening within the internal connection family, where not all designs are the same.

Internal connections represent a major step forward. By moving the contact zone inside the implant body, they reduce lateral force transmission to the crestal bone and provide greater mechanical stability. But within the internal connection category, there is a design difference that most clinicians don't fully appreciate.

Flat-to-flat internal connections — including internal hex — are manufactured with intentional dimensional tolerance. The abutment is designed to be slightly smaller than the internal chamber to allow consistent seating across a manufacturing line. This is an engineering necessity.

The clinical consequence: micromovement is literally built into the design.

That small gap in tolerance — invisible to the naked eye — permits microdisplacement under load. The connection moves. The pump action occurs. The bone responds.

Conical connections solve this at the design level. The tapered geometry between implant and abutment generates friction upon seating that increases under load — the opposite of what happens with flat-to-flat designs. A well-designed conical connection is manufactured with limited to no tolerance. As load is applied, the taper wedges tighter. At a deep enough taper angle and adequate connection depth, this achieves a near cold-weld effect: the connection becomes more stable under function — the exact conditions that destabilize flat-to-flat designs.

The result is less micromovement, less bacterial pumping, less inflammatory stimulation, and better marginal bone levels. Caricasulo and colleagues (2018) confirmed this directly: conical implant-abutment designs provided the best results for implant survival, peri-implant marginal bone loss, and prosthetic complications across all connection geometries compared.

"Conical connection" is a design category, not a single standard — and quality within the category varies. Four factors determine how well a conical connection actually performs:

When evaluating systems, these are the questions worth asking — not what the marketing says, but what the geometry actually is.

A common practice among implant clinicians is placing chlorhexidine gel or antibiotic paste inside the implant connection prior to abutment seating — with the idea that reducing bacterial load at the interface will protect crestal bone.

The problem: it addresses the wrong mechanism.

Yes, the connection harbors bacteria. But the primary driver of crestal bone loss is micromovement, not bacterial colonization alone. A gel does nothing to reduce connection instability. It doesn't change the tolerance, the taper angle, or the locking mechanics. Whatever antimicrobial effect it provides is transient and fails to address the fundamental biologic driver.

If you want to protect crestal bone at the connection, choose a connection that doesn't move. That's the answer.

When you combine a conical connection with platform switching and subcrestal placement, something remarkable becomes achievable: bone levels not just at the implant platform, but above it.

Degidi and colleagues found that all subcrestally placed implants in their cohort showed bone levels above the platform. A separate analysis found that 95% of subcrestally placed implants demonstrated supracrestal bone, with implants placed 2mm subcrestal maintaining approximately 1.5mm of bone coronal to the platform. Equicrestal implants, by contrast, showed marginal bone loss of 0.5–1.5mm — the expected result when you give the biology no room to work.

Bone above the platform is not a lucky outcome. It's a predictable one — when the connection is stable, the platform is switched, and the implant is placed at the right depth. That is the standard worth aiming for.